China News Service, March 8 (Reporter Chen Jing) Diseases such as gynecological tumors and breast tumors are increasingly becoming problems that plague women's health.

The reporter learned during a visit on the 8th that this obstetrics and gynecology specialist hospital is exploring the establishment of a comprehensive treatment system for female malignant tumors, which integrates surgical treatment, radiotherapy, chemotherapy and other treatment methods, so as to achieve precise treatment for female patients with malignant tumors. Improve the survival rate of patients and reduce the recurrence rate.

　　During the interview, the reporter learned that more than 70% of patients with malignant tumors need to receive radiotherapy during their comprehensive treatment.

In the past, most patients still had to go to other general hospitals for radiotherapy after receiving surgical treatment in obstetrics and gynecology specialist hospitals.

While this brings inconvenience to patients, it is also difficult for doctors to manage the whole course of the disease.

Wang Xipeng pointed out that HPV vaccination is the first and most important line of defense to eliminate cervical cancer.

Photo courtesy of the interviewee

　　Wan Xiaoping, the dean of Shanghai First Maternity and Infant Health Hospital (the First Maternity and Infant Health Hospital affiliated to Tongji University, hereinafter referred to as "One Maternal and Infant"), introduced to reporters on the 8th that there are many ways to treat malignant tumors. Radiotherapy is through radiation. Inhibit tumor growth, so as to achieve the purpose of treatment.

In the treatment of common gynecological malignant tumors, cervical cancer, endometrial cancer, etc. can be treated with single radiotherapy or concurrent radiotherapy and chemotherapy, adjuvant radiotherapy before and after surgery; ovarian cancer, etc., if there is organ metastasis, etc., and chemotherapy Radiotherapy can also be considered when it is not sensitive.

The expert explained with an example that radical cervical cancer radiotherapy and perioperative radiotherapy can increase the radical cure rate of cervical cancer from about 40% to about 70%.

　　On the 8th, the radiotherapy department of the hospital took the lead to officially operate.

Wan Xiaoping said that this means that the previous embarrassment will be broken. The obstetrics and gynecology specialist hospital can provide more effective and precise treatment for female patients with malignant tumors, and can manage female tumor patients throughout the process.

"We can make patient follow-up work more refined, which can improve the survival rate of cancer patients and reduce the recurrence rate."

　　During the interview, the reporter learned that among gynecological malignancies, cervical cancer is the only cancer with a clear cause and can be directly prevented by vaccination.

High-risk HPV infection is the main cause of cervical cancer.

Multiple sexual partners, starting sexual life too early, having sex with sexual partners infected with HPV, and decreased self-resistance may all lead to persistent high-risk HPV infections.

　　Professor Wang Xipeng, director of the Department of Obstetrics and Gynecology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, and administrative director of the Reproductive Center, said in an interview with reporters on the 8th that the peak age of cervical cancer in China is showing a younger trend, and a peak of high-risk HPV infection is 15-24 years old. .

This expert believes that the HPV vaccine is launched later in China than abroad, and the scientific understanding of the HPV vaccine should be strengthened by the Chinese people.

　　Wang Xipeng pointed out that HPV vaccination is the first and most important line of defense to eliminate cervical cancer; at the same time, women who have been vaccinated with HPV vaccine should take secondary prevention and regularly undergo cervical cancer screening to build a double guarantee of vaccine and screening.

Regarding the HPV vaccine, Wang Xipeng believes that there is almost no difference in the effectiveness of the several HPV vaccines currently available in preventing cervical cancer caused by the high-risk HPV virus; and complete HPV vaccination can provide women with sufficient protection for a long time.

He told reporters that sexually active women of childbearing age are susceptible to HPV infection; if cervical cancer occurs during pregnancy, it often progresses more rapidly.

Therefore, women who are preparing for pregnancy should be screened for cervical cancer in time before pregnancy. If time permits, it is recommended to vaccinate HPV vaccine as soon as possible when preparing for pregnancy.

　　In fact, the prevention of cervical cancer not only requires attention from women, but there are also "high-risk groups" among men.

Wang Xipeng told reporters that "high-risk men" refer to those who have suffered from cervical cancer among female partners in previous sex lives.

The expert emphasized that the protection of sex life is very important.

(Finish)